Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$7.96 - $12.37 $1,751 - $2,721
-220 Reduced 0.85%
25,653 $271,000
Q4 2023

Feb 13, 2024

SELL
$4.9 - $12.86 $514 - $1,350
-105 Reduced 0.4%
25,873 $310,000
Q3 2023

Nov 13, 2023

BUY
$7.0 - $11.26 $6,468 - $10,404
924 Added 3.69%
25,978 $181,000
Q2 2023

Aug 04, 2023

BUY
$7.61 - $9.46 $3,652 - $4,540
480 Added 1.95%
25,054 $212,000
Q1 2023

May 12, 2023

BUY
$8.83 - $17.61 $4,309 - $8,593
488 Added 2.03%
24,574 $224,000
Q4 2022

Feb 10, 2023

SELL
$10.88 - $20.05 $946 - $1,744
-87 Reduced 0.36%
24,086 $274,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $5,492 - $9,025
342 Added 1.44%
24,173 $411,000
Q2 2022

Aug 12, 2022

SELL
$20.49 - $39.72 $26,391 - $51,159
-1,288 Reduced 5.13%
23,831 $512,000
Q1 2022

May 13, 2022

SELL
$28.19 - $46.6 $49,839 - $82,388
-1,768 Reduced 6.58%
25,119 $929,000
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $33,166 - $59,247
-805 Reduced 2.91%
26,887 $1.22 Million
Q3 2021

Nov 12, 2021

SELL
$59.15 - $91.99 $20,643 - $32,104
-349 Reduced 1.24%
27,692 $1.76 Million
Q2 2021

Aug 13, 2021

SELL
$63.02 - $95.11 $77,010 - $116,224
-1,222 Reduced 4.18%
28,041 $2.57 Million
Q1 2021

May 07, 2021

BUY
$57.62 - $95.6 $82,396 - $136,708
1,430 Added 5.14%
29,263 $1.99 Million
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $33,061 - $61,517
-798 Reduced 2.79%
27,833 $2.02 Million
Q3 2020

Nov 04, 2020

BUY
$30.88 - $37.94 $75,532 - $92,801
2,446 Added 9.34%
28,631 $1.09 Million
Q2 2020

Aug 12, 2020

BUY
$18.95 - $35.43 $34,868 - $65,191
1,840 Added 7.56%
26,185 $928,000
Q1 2020

May 04, 2020

SELL
$13.94 - $28.25 $19,599 - $39,719
-1,406 Reduced 5.46%
24,345 $531,000
Q4 2019

Feb 05, 2020

SELL
$19.24 - $28.41 $4,155 - $6,136
-216 Reduced 0.83%
25,751 $555,000
Q3 2019

Nov 08, 2019

SELL
$20.03 - $40.08 $3,625 - $7,254
-181 Reduced 0.69%
25,967 $587,000
Q2 2019

Aug 13, 2019

BUY
$25.78 - $39.77 $96,958 - $149,574
3,761 Added 16.8%
26,148 $941,000
Q1 2019

May 06, 2019

SELL
$22.09 - $39.21 $16,015 - $28,427
-725 Reduced 3.14%
22,387 $706,000
Q4 2018

Feb 13, 2019

BUY
$19.89 - $30.02 $20,267 - $30,590
1,019 Added 4.61%
23,112 $581,000
Q3 2018

Nov 09, 2018

BUY
$12.1 - $28.85 $12,487 - $29,773
1,032 Added 4.9%
22,093 $637,000
Q2 2018

Aug 08, 2018

BUY
$7.93 - $15.79 $167,013 - $332,553
21,061 New
21,061 $258,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.